
-
Iconic Bayeux Tapestry to be loaned to Britain: French president
-
Lyles to make 200m return against Tebogo in Monaco
-
UK post office scandal may have caused 13 suicides: inquiry
-
Some Europeans still travel to Iran, ignoring dire warnings
-
ICC seeks arrest of Taliban leaders over persecution of women
-
Stocks mark time as Trump postpones tariffs deadline
-
India expect England's Archer to pose 'challenge'
-
Springboks make 11 changes for Italy Test
-
Liverpool return to training in wake of Jota death
-
France's Marseille airport says closing due to nearby wildfire
-
France's Macron kicks off 'historic' UK state visit
-
Aussie prop Tupou hopes Racing move will bring smile back
-
Speeding likely cause of Diogo Jota car crash: police
-
Bulgaria becomes 21st member to adopt euro after EU green light
-
'Free culture': Slovak gunman defends Fico shooting as trial begins
-
Rome to host Ukraine recovery conference as US support falters
-
Qatar says 'we will need time' for Gaza ceasefire
-
Alcaraz faces Norrie test at Wimbledon, Sabalenka eyes semi-finals
-
Forest fire blazes in southern France
-
Indian villagers beat five to death for 'witchcraft'
-
Gaza ceasefire talks resume as Trump upbeat on deal
-
Stocks rise as Trump delays tariffs deadline
-
Acropolis shuts, outdoor work halted as heatwave scorches Greece
-
Newcastle agree £55m fee for Forest's Elanga - reports
-
German exports to US tumble as Berlin urges quick trade deal
-
Tottenham sign Japan defender Takai
-
Cambodian garment workers fret Trump's new tariff threat
-
Israel-Hamas ceasefire negotiations resume as Trump pushes for deal
-
Trial of Slovak gunman who shot PM begins
-
Wallabies' Lolesio faces long rehab after surgery
-
Lions not invincible says former All Blacks coach Foster
-
Markets rise as Trump sends tariff letters, delays deadline
-
Australia-born Lion Hansen faces 'pinch-me' moment against old team
-
Mitre by mitre: N. Macedonian nuns craft priceless holy headwear
-
S.Leone islanders despair as rising ocean threatens survival
-
Bulgaria to get final green light to adopt euro in 2026
-
Major garment producer Bangladesh seeks deal after 35% US tariff
-
France's Macron kicks off pomp-filled UK state visit
-
Mbappe and PSG set for Club World Cup reunion as Real Madrid eye final
-
US to send 'more weapons' to Ukraine: Trump
-
Most markets rise as Trump sends tariff letters, delays deadline
-
Slovak gunman who shot PM to go on trial
-
As heatwaves intensify, Morocco ups effort to warn residents
-
All Blacks captain Scott Barrett out for rest of France series
-
AI video becomes more convincing, rattling creative industry
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
Battery Asset Management Summit Launches in Australia to Power the Nation's Energy Revolution

Kairos Pharma to Participate in The Microcap Conference in January 2025
Kairos Pharma, (NYSE American:KAPA) a clinical stage biotechnology company is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Kairos Pharma's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About Kairos Pharma Ltd.
Based in Los Angeles, California, Kairos Pharma Ltd. (NYSE American:KAPA) is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. Our lead candidate, ENV105, is an antibody that targets CD105-a protein identified as a key driver of resistance to various cancer treatments. Elevation of CD105 in response to standard therapy results in resistance and disease relapse. ENV105 aims to reverse drug resistance by targeting CD105 and restore the effectiveness of standard therapies across multiple cancer types. Currently, ENV105 is in a Phase 2 clinical trial for castrate-resistant prostate cancer and a Phase 1 trial for lung cancer aimed at addressing significant unmet medical needs. For more information, visit kairospharma.com.
Contact:
CORE IR
Louie Toma
[email protected]
SOURCE: Kairos Pharma Ltd.
P.Costa--AMWN